Clinical trials: Smoking, Tobacco
Chronic Obstructive Pulmonary Disease, Emphysema
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
Obstructive lung disease is an increasing global health problem of pandemic proportions, with COPD alone affecting >10% of the population. Smoking is the main and most well studies risk factor for developing COPD.
- Conditions
- Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Airway Obstruction
- Trial name
- BRONCOSCAPIS (NCT03049202)
- Where
- 6 sites in Sweden
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Karolinska Institutet
Vaping
Influencer Marketing: a Survey-based Experiment Among Adolescents
Adolescents (N = 664) participated in the online survey-based experiment. They were randomly shown 10 videos, featuring influencers promoting e-cigarettes alongside healthy lifestyle activities (experimental group), or…
- Trial name
- NCT06501937
- Testing
- Influencer marketing
- Where
- United States
- Volunteers
- 664 people
- Sponsor
- University of Southern California
Waterpipe Smoking
Assessing Toxicity of Waterpipe Tobacco Smoking
Waterpipe smoking is a tobacco use method in which smoke passes through a partially-filled water jar. Burning charcoal heats the waterpipe tobacco which produces the smoke that the user inhales.
- Trial name
- NCT03253653
- Testing
- Differential effects of waterpipe smoking practices on toxicity of waterpipe tobacco smoke
- Where
- United States
- Volunteers
- 85 people, healthy volunteers welcome
- Sponsor
- San Diego State University
Airway Morbidity, Smoking Cessation
Adverse Airway Effects From Tobacco and E-Cigarettes
The purpose of the study conducted at VA Medical Center in Miami is to determine if smoking electronic cigarettes (known as e-cigarettes) that contain nicotine have less negative effects than regular cigarettes on the person's…
- Conditions
- Airway Morbidity, Smoking Cessation, Nicotine Adverse Reaction, Smoking, Tobacco
- Trial name
- NCT03251053
- Testing
- Electronic cigarette use, Control regular cigarette smokers
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Miami VA Healthcare System
E Cigarette Use
Impact of Aversive Warnings on E-Cigarette Cessation
This project aims to evaluate the effectiveness of aversive visual health warnings on e-cigarette cessation among young adults through a randomized controlled trial, as e-cigarette use among this population has been steadily…
- Trial name
- NCT05892445
- Testing
- Graphic Warning Labels
- Volunteers
- 1,000 people
- Sponsor
- University of California, San Diego
Chronic Obstructive Pulmonary Disease, Emphysema
Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD) is an increasing global health problem, which primarily increases among the female population.
- Conditions
- Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Chronic Airways Obstruction
- Trial name
- COSMIC (NCT02627872)
- Where
- Sweden
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Karolinska Institutet
Cigarette Smoking
Investigation of Nicotine Seeking Behavior in Current Smokers
In this study, 21 non-treatment-seeking cigarette smokers were recruited to investigate the effects of acute stress on brain function and nicotine seeking/self-administration behavior.
- Trial name
- NSS (NCT03670212)
- Testing
- Yohimbine Hydrochloride, Hydrocortisone, Lactose Monohydrate Powder
- Where
- United States
- Volunteers
- 21 people
- Sponsor
- Wayne State University
Smoking ( Cigarette)
Effect of Buteyko Breathing Exercise Combined With Postural Stability Exercises on Maximal Oxygen Consumption in Young Adult Smokers
Background: Smoking is one of the most significant risk factors for respiratory diseases, affecting both lung function and overall respiratory health.
- Trial name
- BBE PSE VO2max (NCT07257783)
- Testing
- Buteyko breathing exercise combined with postural stability exercises
- Where
- Egypt
- Volunteers
- 46 people
- Sponsor
- Yasmeen Alaa Abd El-Hamied Ahmeed
Number of Quit Attempts
Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging
Background: Quitting smoking is hard. It is easy to relapse. Smokers may think of temptation to smoke as a threat if they think it suggests that they are unable to meet the challenges of stopping.
- Trial name
- NCT03027466
- Testing
- Self-affirmation induction
- Where
- United States
- Volunteers
- 7,899 people
- Sponsor
- National Cancer Institute (NCI)
Smoking
Short Term Effect of Interscapular Cupping on Chest Expansion in Sedentary Male Smokers
Although cupping remains a popular treatment modality worldwide, its efficacy for most health issues has not been scientifically evaluated so further studies are needed .
- Trial name
- NCT04238182
- Testing
- wet cupping, dry cupping
- Where
- Egypt
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Cairo University
Smoking Cessation, Substance Use Disorder
Intensive Referral to Reduce Smoking in Probationers
The purpose of this study is to determine if Intensive Referral Intervention increases motivation to quit cigarette smoking and quitting-related behaviors in probationers and also to determine if Intensive Referral Intervention…
- Trial name
- NCT03042650
- Testing
- Intensive Referral Intervention Group, Standard Practice Facilitated Group
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- University of Nebraska
Vaping, Cessation, Tobacco
Text Message Quit Vaping Intervention for Adolescents
This research study, conducted by Truth Initiative, will help us learn how text messaging can help adolescents between 13 and 17 years of age quit vaping.
- Trial name
- NCT04919590
- Testing
- This is Quitting, Assessment only control, Waitlist control
- Where
- United States
- Volunteers
- 1,681 people, healthy volunteers welcome
- Sponsor
- Truth Initiative
Alcohol Use Disorder (AUD), Nicotine Use Disorder
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among…
- Trial name
- PERRAS (NCT05181891)
- Testing
- Contingency Management, Non-contingent control
- Where
- United States
- Volunteers
- 205 people, healthy volunteers welcome
- Sponsor
- Washington State University
Smoking Cessation, Pharmacokinetics
A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"
A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics after Administration of the "CDFF0318" and "Champix Tab. 1mg (Varenicline tartrate)" in Healthy Male Volunteers
- Trial name
- NCT04631874
- Testing
- CDFF0318, Champix
- Where
- South Korea
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- CTC Bio, Inc.
Cigarette Smoking
Contingency Management and Pharmacotherapy for Smoking Cessation
In total, 70 smokers will be randomized to: standard of care smoking cessation medication varenicline alone (an FDA-approved smoking cessation medication) or varenicline plus contingency management (CM) (a behavioral procedure…
- Trial name
- Donaghue (NCT00683280)
- Testing
- contingency management, Standard of Care
- Where
- United States
- Volunteers
- 59 people
- Sponsor
- UConn Health
Tobacco Use, Tobacco Cessation
A Brief Digital Screening Tool to Address Tobacco and E-cigarette Use in Pediatric Medical Care
Tobacco use is the single greatest preventable cause of morbidity and mortality in Canada, accounting for 48,000 deaths and $16.2 billion annually in attributable health-related costs.
- Conditions
- Tobacco Use, Tobacco Cessation, Second Hand Tobacco Smoke, Smoking, Tobacco
- Trial name
- CanCEASE (NCT05366790)
- Testing
- CEASE and CEASE-A
- Where
- Canada
- Volunteers
- 130 people
- Sponsor
- St. Justine's Hospital
Smoking Cessation
Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)
The purpose of this study is to collect the efficacy and safety information in subjects who have been retreated with varenicline (Champix®) within 52 weeks of initial treatment for their appropriate use in daily practice and are…
- Trial name
- NCT01061710
- Testing
- varenicline
- Volunteers
- 20 people
- Sponsor
- Pfizer
Smoking
Brief Tobacco Cessation Intervention
Traditional smoking cessation clinics and telephone quitlines are expensive and 'passive' as they require motivated smokers to visit the clinic or make a phone call to seek help.
- Trial name
- NCT02494960
- Testing
- The brief smoking cessation AWARD model
- Where
- China
- Volunteers
- 13,671 people
- Sponsor
- The University of Hong Kong
Smoking Cessation
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
It is possible to offer smoking cessation treatment including varenicline to patients scheduled for elective surgery. This study will evaluate whether or not this will enable some patients to quit smoking for up to 4 weeks prior…
- Trial name
- NCT00889720
- Testing
- Varenicline
- Where
- 2 sites in France, Italy
- Volunteers
- 16 people
- Sponsor
- Pfizer
Smoking, Smoking, Tobacco
Financial Incentives for Smoking Treatment
The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the…
- Conditions
- Smoking, Smoking, Tobacco, Tobacco Use Disorder
- Trial name
- FIESTA (NCT02506829)
- Testing
- Smoking cessation counseling (Quitline), Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy), Financial incentives
- Where
- United States
- Volunteers
- 182 people
- Sponsor
- NYU Langone Health
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.